Epigenetic regulation in the pathophysiology of Alzheimer's disease

Progress in Neurobiology

Volumn 90, Issue 4, 2010, Pages 498-510

  Chouliaras, Leonidas ^a   Rutten, Bart P F ^a   Kenis, Gunter ^a   Peerbooms, Odette ^a   Visser, Pieter Jelle ^a,b   Verhey, Frans ^a   van Os, Jim ^a,c   Steinbusch, Harry W M ^a   van den Hove, Daniel L A ^a,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Aging; Alzheimer's disease; Dementia; DNA methylation; Epigenetics; Gene environment interactions; Histone

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; HISTONE; HISTONE DEACETYLASE INHIBITOR;

AGING; ALZHEIMER DISEASE; ANIMAL CELL CULTURE; COGNITIVE DEFECT; DISEASE COURSE; DISEASE MARKER; DNA DAMAGE; DNA METHYLATION; DNA PROTEIN COMPLEX; DNA SEQUENCE; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE INTERACTION; GENETIC PREDISPOSITION; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HEREDITY; HUMAN; LEUKOCYTE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRANSGENIC ANIMAL;

AGING; ALZHEIMER DISEASE; ANIMALS; DNA METHYLATION; ENVIRONMENT; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HISTONES; HUMANS;

EID: 77950866465     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2010.01.002     Document Type: Review

References (165)

1. Abdolmaleky H.M., Smith C.L., Faraone S.V., Shafa R., Stone W., Glatt S.J., Tsuang M.T. Methylomics in psychiatry: modulation of gene-environment interactions may be through DNA methylation. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2004, 127B:51-59.
2. Abel T., Zukin R.S. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr. Opin. Pharmacol. 2008, 8:57-64.
3. Anekonda T.S., Reddy P.H. Neuronal protection by sirtuins in Alzheimer's disease. J. Neurochem. 2006, 96:305-313.
4. Bannister A.J., Kouzarides T. Reversing histone methylation. Nature 2005, 436:1103-1106.
5. Barrachina M., Ferrer I. DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J. Neuropathol. Exp. Neurol. 2009, 68:880-891.
6. Bassett S.S., Avramopoulos D., Fallin D. Evidence for parent of origin effect in late-onset Alzheimer disease. Am. J. Med. Genet. 2002, 114:679-686.
7. Belyaev N.D., Nalivaeva N.N., Makova N.Z., Turner A.J. Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep. 2009, 10:94-100.
8. Bergem A.L., Engedal K., Kringlen E. The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. Arch. Gen. Psychiatry 1997, 54:264-270.
9. Berger S.L. The complex language of chromatin regulation during transcription. Nature 2007, 447:407-412.
10. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 2007, 39:17-23.
11. Bezprozvanny I., Mattson M.P. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 2008, 31:454-463.
12. Bird T.D. Genetic factors in Alzheimer's disease. N. Engl. J. Med. 2005, 352:862-864.
13. Bird T.D. Genetic aspects of Alzheimer disease. Genet. Med. 2008, 10:231-239.
14. Bollati V., Schwartz J., Wright R., Litonjua A., Tarantini L., Suh H., Sparrow D., Vokonas P., Baccarelli A. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech. Ageing Dev. 2009, 130:234-239.
15. Borenstein A.R., Copenhaver C.I., Mortimer J.A. Early-life risk factors for Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2006, 20:63-72.
16. Borenstein A.R., Wu Y., Mortimer J.A., Schellenberg G.D., McCormick W.C., Bowen J.D., McCurry S., Larson E.B. Developmental and vascular risk factors for Alzheimer's disease. Neurobiol. Aging 2005, 26:325-334.
17. Breitner J.C., Welsh K.A., Gau B.A., McDonald W.M., Steffens D.C., Saunders A.M., Magruder K.M., Helms M.J., Plassman B.L., Folstein M.F., et al. Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Arch. Neurol. 1995, 52:763-771.
18. Brickell K.L., Leverenz J.B., Steinbart E.J., Rumbaugh M., Schellenberg G.D., Nochlin D., Lampe T.H., Holm I.E., Van Deerlin V., Yuan W., Bird T.D. Clinic pathological concordance and discordance in three monozygotic twin pairs with familial Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78:1050-1055.
19. Brunet A. Cancer: when restriction is good. Nature 2009, 458:713-714.
20. Bu G. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 2009, 10:333-344.
21. Burns A., Iliffe S. Alzheimer's disease. BMJ 2009, 338:b158.
22. Cao X., Sudhof T.C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001, 293:115-120.
23. Cavallaro R.A., Fuso A., D'Anselmi F., Seminara L., Scarpa S. The effect of S-adenosylmethionine on CNS gene expression studied by cDNA microarray analysis. J. Alzheimers Dis. 2006, 9:415-419.
24. Cedar H., Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 2009, 10:295-304.
25. Chen D., Bruno J., Easlon E., Lin S.J., Cheng H.L., Alt F.W., Guarente L. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 2008, 22:1753-1757.
26. Chen D., Steele A.D., Hutter G., Bruno J., Govindarajan A., Easlon E., Lin S.J., Aguzzi A., Lindquist S., Guarente L. The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration. Exp. Gerontol. 2008, 43:1086-1093.
27. Chen K.L., Wang S.S., Yang Y.Y., Yuan R.Y., Chen R.M., Hu C.J. The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells. Biochem. Biophys. Res. Commun. 2009, 378:57-61.
28. Christensen B.C., Houseman E.A., Marsit C.J., Zheng S., Wrensch M.R., Wiemels J.L., Nelson H.H., Karagas M.R., Padbury J.F., Bueno R., Sugarbaker D.J., Yeh R.F., Wiencke J.K., Kelsey K.T. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 2009, 5:e1000602.
29. Chuang D.-M., Leng Y., Marinova Z., Kim H.-J., Chiu C.-T. Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 2009, 32:591-601.
30. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., Allison D.B., Cruzen C., Simmons H.A., Kemnitz J.W., Weindruch R. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325:201-204.
31. Cummings J.L. Alzheimer's disease. N. Engl. J. Med. 2004, 351:56-67.
32. de Carvalho C.V., Payao S.L., Smith M.A. DNA methylation, ageing and ribosomal genes activity. Biogerontology 2000, 1:357-361.
33. Di Fede G., Catania M., Morbin M., Rossi G., Suardi S., Mazzoleni G., Merlin M., Giovagnoli A.R., Prioni S., Erbetta A., Falcone C., Gobbi M., Colombo L., Bastone A., Beeg M., Manzoni C., Francescucci B., Spagnoli A., Cantu L., Del Favero E., Levy E., Salmona M., Tagliavini F. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 2009, 323:1473-1477.
34. Dickson D.W. Neuropathology of Alzheimer's disease and other dementias. Clin. Geriatr. Med. 2001, 17:209-228.
35. Ding H., Dolan P.J., Johnson G.V. Histone deacetylase 6 interacts with the microtubule-associated protein tau. J. Neurochem. 2008, 106:2119-2130.
36. Drake J., Petroze R., Castegna A., Ding Q., Keller J.N., Markesbery W.R., Lovell M.A., Butterfield D.A. 4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease. Neurosci. Lett. 2004, 356:155-158.
37. El-Maarri O., Kareta M.S., Mikeska T., Becker T., Diaz-Lacava A., Junen J., Nusgen N., Behne F., Wienker T., Waha A., Oldenburg J., Chedin F. A systematic search for DNA methyltransferase polymorphisms reveals a rare DNMT3L variant associated with subtelomeric hypomethylation. Hum. Mol. Genet. 2009, 18:1755-1768.
38. Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol. 2003, 4:351-358.
39. Esteve P.O., Chin H.G., Smallwood A., Feehery G.R., Gangisetty O., Karpf A.R., Carey M.F., Pradhan S. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev. 2006, 20:3089-3103.
40. EU-GEI Schizophrenia aetiology: do gene-environment interactions hold the key?. Schizophr. Res. 2008, 102:21-26.
41. Evans R.M., Hui S., Perkins A., Lahiri D.K., Poirier J., Farlow M.R. Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology 2004, 62:1869-1871.
42. Farrer L.A., Cupples L.A., Connor L., Wolf P.A., Growdon J.H. Association of decreased paternal age and late-onset Alzheimer's disease. An example of genetic imprinting?. Arch. Neurol. 1991, 48:599-604.
43. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age, sex, and ethnicity on the association between Apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997, 278:1349-1356.
44. Felsenfeld G., Groudine M. Controlling the double helix. Nature 2003, 421:448-453.
45. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M. Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117.
46. Fischer A., Sananbenesi F., Wang X., Dobbin M., Tsai L.H. Recovery of learning and memory is associated with chromatin remodelling. Nature 2007, 447:178-182.
47. Foley D.L., Craig J.M., Morley R., Olsson C.J., Dwyer T., Smith K., Saffery R. Prospects for epigenetic epidemiology. Am. J. Epidemiol. 2009, 169:389-400.
48. Fraga M.F. Genetic and epigenetic regulation of aging. Curr. Opin. Immunol. 2009, 21:446-453.
49. Fraga M.F., Agrelo R., Esteller M. Cross-talk between aging and cancer: the epigenetic language. Ann. N. Y. Acad. Sci. 2007, 1100:60-74.
50. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., Heine-Suner D., Cigudosa J.C., Urioste M., Benitez J., Boix-Chornet M., Sanchez-Aguilera A., Ling C., Carlsson E., Poulsen P., Vaag A., Stephan Z., Spector T.D., Wu Y.Z., Plass C., Esteller M. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10604-10609.
51. Fraga M.F., Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet. 2007, 23:413-418.
52. Francis Y.I., Fa M., Ashraf H., Zhang H., Staniszewski A., Latchman D.S., Arancio O. Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease. J. Alzheimers Dis. 2009, 18:131-139.
53. Franklin T.B., Mansuy I.M. Epigenetic inheritance in mammals: evidence for the impact of adverse environmental effects. Neurobiol. Dis. 2009.
54. Fuks F., Burgers W.A., Brehm A., Hughes-Davies L., Kouzarides T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 2000, 24:88-91.
55. Fuks F., Hurd P.J., Wolf D., Nan X., Bird A.P., Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 2003, 278:4035-4040.
56. Fuso A., Cavallaro R.A., Zampelli A., D'Anselmi F., Piscopo P., Confaloni A., Scarpa S. Gamma-secretase is differentially modulated by alterations of homocysteine cycle in neuroblastoma and glioblastoma cells. J. Alzheimers Dis. 2007, 11:275-290.
57. Fuso A., Nicolia V., Pasqualato A., Fiorenza M.T., Cavallaro R.A., Scarpa S. Changes in presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency. Neurobiol. Aging 2009.
58. Fuso, A., Nicolia, V., Pasqualato, A., Fiorenza, M. T., Cavallaro, R. A. and Scarpa, S. Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency. Neurobiology of Aging, in press, corrected proof.
59. Gatz M., Fratiglioni L., Johansson B., Berg S., Mortimer J.A., Reynolds C.A., Fiske A., Pedersen N.L. Complete ascertainment of dementia in the Swedish Twin Registry: the HARMONY study. Neurobiol. Aging 2005, 26:439-447.
60. Gatz M., Reynolds C.A., Fratiglioni L., Johansson B., Mortimer J.A., Berg S., Fiske A., Pedersen N.L. Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 2006, 63:168-174.
61. Gluckman P.D., Hanson M.A., Buklijas T., Low F.M., Beedle A.S. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat. Rev. Endocrinol. 2009, 5:401-408.
62. Goldberg A.D., Allis C.D., Bernstein E. Epigenetics: a landscape takes shape. Cell 2007, 128:635-638.
63. Goll M.G., Kirpekar F., Maggert K.A., Yoder J.A., Hsieh C.-L., Zhang X., Golic K.G., Jacobsen S.E., Bestor T.H. Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2. Science 2006, 311:395-398.
64. Graff J., Mansuy I.M. Epigenetic codes in cognition and behaviour. Behav. Brain Res. 2008, 192:70-87.
65. Green K.N., Billings L.M., Roozendaal B., McGaugh J.L., LaFerla F.M. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J. Neurosci. 2006, 26:9047-9056.
66. Green K.N., Steffan J.S., Martinez-Coria H., Sun X., Schreiber S.S., Thompson L.M., LaFerla F.M. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J. Neurosci. 2008, 28:11500-11510.
67. Guan J.-S., Haggarty S.J., Giacometti E., Dannenberg J.-H., Joseph N., Gao J., Nieland T.J.F., Zhou Y., Wang X., Mazitschek R., Bradner J.E., DePinho R.A., Jaenisch R., Tsai L.-H. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009, 459:55-60.
68. Haigis M.C., Guarente L.P. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev. 2006, 20:2913-2921.
69. Hakansson K., Rovio S., Helkala E.L., Vilska A.R., Winblad B., Soininen H., Nissinen A., Mohammed A.H., Kivipelto M. Association between mid-life marital status and cognitive function in later life: population based cohort study. BMJ 2009, 339:b2462.
70. Hardy J. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J. Neurochem. 2009, 110:1129-1134.
71. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M.L., Pahwa, J.S., Moskvina, V., Dowzell, K., Williams, A., Jones, N., Thomas, C., Stretton, A., Morgan, A.R., Lovestone, S., Powell, J., Proitsi, P., Lupton, M.K., Brayne, C., Rubinsztein, D.C., Gill, M., Lawlor, B., Lynch, A., Morgan, K., Brown, K.S., Passmore, P.A., Craig, D., McGuinness, B., Todd, S., Holmes, C., Mann, D., Smith, A.D., Love, S., Kehoe, P.G., Hardy, J., Mead, S., Fox, N., Rossor, M., Collinge, J., Maier, W., Jessen, F., Schurmann, B., van den Bussche, H., Heuser, I., Kornhuber, J., Wiltfang, J., Dichgans, M., Frolich, L., Hampel, H., Hull, M., Rujescu, D., Goate, A.M., Kauwe, J.S. K., Cruchaga, C., Nowotny, P., Morris, J.C., Mayo, K., Sleegers, K., Bettens, K., Engelborghs, S., De Deyn, P.P., Van Broeckhoven, C., Livingston, G., Bass, N.J., Gurling, H., McQuillin, A., Gwilliam, R., Deloukas, P., Al-Chalabi, A., Shaw, C.E., Tsolaki, M., Singleton, A.B., Guerreiro, R., Muhleisen, T.W., Nothen, M.M., Moebus, S., Jockel, K.-H., Klopp, N., Wichmann, H.E., Carrasquillo, M.M., Pankratz, V.S., Younkin, S.G., Holmans, P.A., O'Donovan, M., Owen, M.J., Williams, J., 2009. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet., advance online publication.
72. Huang H.C., Jiang Z.F. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease. J. Alzheimers Dis. 2009, 16:15-27.
73. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 2003, 33(Suppl.):245-254.
74. Jones P.A., Liang G. Rethinking how DNA methylation patterns are maintained. Nat. Rev. Genet. 2009, 10:805-811.
75. Kalaany N.Y., Sabatini D.M. Tumours with PI3K activation are resistant to dietary restriction. Nature 2009, 458:725-731.
76. Kalaria R.N., Maestre G.E., Arizaga R., Friedland R.P., Galasko D., Hall K., Luchsinger J.A., Ogunniyi A., Perry E.K., Potocnik F., Prince M., Stewart R., Wimo A., Zhang Z.X., Antuono P. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008, 7:812-826.
77. Kalman J., Kitajka K., Pakaski M., Zvara A., Juhasz A., Vincze G., Janka Z., Puskas L.G. Gene expression profile analysis of lymphocytes from Alzheimer's patients. Psychiatr. Genet. 2005, 15:1-6.
78. Kaminsky Z., Wang S.C., Petronis A. Complex disease, gender and epigenetics. Ann. Med. 2006, 38:530-544.
79. Kennedy B.P., Bottiglieri T., Arning E., Ziegler M.G., Hansen L.A., Masliah E. Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function. J. Neural Transm. 2004, 111:547-567.
80. Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., Delalle I., Baur J.A., Sui G., Armour S.M., Puigserver P., Sinclair D.A., Tsai L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007, 26:3169-3179.
81. Kountouras J., Tsolaki M., Gavalas E., Boziki M., Zavos C., Karatzoglou P., Chatzopoulos D., Venizelos I. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 2006, 66:938-940.
82. Kountouras J., Boziki M., Gavalas E., Zavos C., Grigoriadis N., Deretzi G., Tzilves D., Katsinelos P., Tsolaki M., Chatzopoulos D., Venizelos I. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease. J. Neurol. 2009, 256:758-767.
83. LaFerla F.M., Green K.N., Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat. Rev. Neurosci. 2007, 8:499-509.
84. Lahiri D.K., Farlow M.R., Sambamurti K., Greig N.H., Giacobini E., Schneider L.S. A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr. Drug Targets 2003, 4:97-112.
85. Lahiri D.K., Maloney B., Basha M.R., Ge Y.W., Zawia N.H. How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the " LEARn" model (latent early-life associated regulation) may explain the triggering of AD. Curr. Alzheimer Res. 2007, 4:219-228.
86. Lahiri D.K., Maloney B., Zawia N.H. The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol. Psychiatry 2009, 14:992-1003.
87. Lahiri D.K., Sambamurti K., Bennett D.A. Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease. Neurobiol. Aging 2004, 25:651-660.
88. Lahiri D.K., Zawia N.H., Greig N.H., Sambamurti K., Maloney B. Early-life events may trigger biochemical pathways for Alzheimer's disease: the " LEARn" model. Biogerontology 2008, 9:375-379.
89. Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M.J., Tavernier, B., Letenneur, L., Bettens, K., Berr, C., Pasquier, F., Fievet, N., Barberger-Gateau, P., Engelborghs, S., De Deyn, P., Mateo, I., Franck, A., Helisalmi, S., Porcellini, E., Hanon, O., de Pancorbo, M.M., Lendon, C., Dufouil, C., Jaillard, C., Leveillard, T., Alvarez, V., Bosco, P., Mancuso, M., Panza, F., Nacmias, B., Bossu, P., Piccardi, P., Annoni, G., Seripa, D., Galimberti, D., Hannequin, D., Licastro, F., Soininen, H., Ritchie, K., Blanche, H., Dartigues, J.-F., Tzourio, C., Gut, I., Van Broeckhoven, C., Alperovitch, A., Lathrop, M., Amouyel, P., 2009. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet., advance online publication.
90. Lande-Diner L., Zhang J., Ben-Porath I., Amariglio N., Keshet I., Hecht M., Azuara V., Fisher A.G., Rechavi G., Cedar H. Role of DNA methylation in stable gene repression. J. Biol. Chem. 2007, 282:12194-12200.
91. Law I.K., Liu L., Xu A., Lam K.S., Vanhoutte P.M., Che C.M., Leung P.T., Wang Y. Identification and characterization of proteins interacting with SIRT1 and SIRT3: implications in the anti-aging and metabolic effects of sirtuins. Proteomics 2009, 9:2444-2456.
92. Lin H.C., Hsieh H.M., Chen Y.H., Hu M.L. S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters. Neurotoxicology 2009, 30:622-627.
93. Lithner C.U., Hernandez C.M., Nordberg A., Sweatt J.D. Epigenetic changes related to beta-amyloid-implications for Alzheimer's disease. Alzheimer's Demen. 2009, 5:P304-P1304.
94. Liu L., Li Y., Tollefsbol T.O. Gene-environment interactions and epigenetic basis of human diseases. Curr. Issues Mol. Biol. 2008, 10:25-36.
95. Luchsinger J.A., Gustafson D.R. Adiposity and Alzheimer's disease. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12:15-21.
96. Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8A resolution. Nature 1997, 389:251-260.
97. Lundberg J., Karimi M., von Gertten C., Holmin S., Ekstrom T.J., Sandberg-Nordqvist A.-C. Traumatic brain injury induces relocalization of DNA-methyltransferase 1. Neurosci. Lett. 2009, 457:8-11.
98. Mahley R.W., Weisgraber K.H., Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:5644-5651.
99. Mani S.T., Thakur M.K. In the cerebral cortex of female and male mice, amyloid precursor protein (APP) promoter methylation is higher in females and differentially regulated by sex steroids. Brain Res. 2006, 1067:43-47.
100. Mastroeni D., Grover A., Delvaux E., Whiteside C., Coleman P.D., Rogers J. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol. Aging 2008.
101. Mastroeni D., McKee A., Grover A., Rogers J., Coleman P.D. Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease. PLoS One 2009, 4:e6617.
102. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonte B., Szyf M., Turecki G., Meaney M.J. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat. Neurosci. 2009, 12:342-348.
103. Meaney M.J., Szyf M., Seckl J.R. Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Trends Mol. Med. 2007, 13:269-277.
104. Mehler M.F. Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog. Neurobiol. 2008, 86:305-341.
105. Modrego P.J. Depression in the prodromal phase of Alzheimer disease and the reverse causal hypothesis. Arch. Gen. Psychiatry 2009, 66:107.
106. Modrego P.J., Ferrandez J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch. Neurol. 2004, 61:1290-1293.
107. Moffitt T.E., Caspi A., Rutter M. Strategy for investigating interactions between measured genes and measured environments. Arch. Gen. Psychiatry 2005, 62:473-481.
108. Mudher A., Lovestone S. Alzheimer's disease-do tauists and baptists finally shake hands?. Trends Neurosci. 2002, 25:22-26.
109. Myung N.H., Zhu X., Kruman I.I., Castellani R.J., Petersen R.B., Siedlak S.L., Perry G., Smith M.A., Lee H.G. Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. Age (Dordr.) 2008, 30:209-215.
110. Nakagawa Y., Nakamura M., McIntosh T.K., Rodriguez A., Berlin J.A., Smith D.H., Saatman K.E., Raghupathi R., Clemens J., Saido T.C., Schmidt M.L., Lee V.M., Trojanowski J.Q. Traumatic brain injury in young, amyloid-beta peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Abeta deposition during aging. J. Comp. Neurol. 1999, 411:390-398.
111. Nakagawa Y., Reed L., Nakamura M., McIntosh T.K., Smith D.H., Saatman K.E., Raghupathi R., Clemens J., Saido T.C., Lee V.M., Trojanowski J.Q. Brain trauma in aged transgenic mice induces regression of established abeta deposits. Exp. Neurol. 2000, 163:244-252.
112. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998, 393:386-389.
113. Oberdoerffer P., Michan S., McVay M., Mostoslavsky R., Vann J., Park S.K., Hartlerode A., Stegmuller J., Hafner A., Loerch P., Wright S.M., Mills K.D., Bonni A., Yankner B.A., Scully R., Prolla T.A., Alt F.W., Sinclair D.A. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 2008, 135:907-918.
114. Okita K., Matsukawa N., Maki M., Nakazawa H., Katada E., Hattori M., Akatsu H., Borlongan C.V., Ojika K. Analysis of DNA variations in promoter region of HCNP gene with Alzheimer's disease. Biochem. Biophys. Res. Commun. 2009, 379:272-276.
115. Ooi S.K., Bestor T.H. The colorful history of active DNA demethylation. Cell 2008, 133:1145-1148.
116. Ooi S.K.T., Qiu C., Bernstein E., Li K., Jia D., Yang Z., Erdjument-Bromage H., Tempst P., Lin S.-P., Allis C.D., Cheng X., Bestor T.H. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007, 448:714-717.
117. Perez M., Santa-Maria I., Gomez de Barreda E., Zhu X., Cuadros R., Cabrero J.R., Sanchez-Madrid F., Dawson H.N., Vitek M.P., Perry G., Smith M.A., Avila J. Tau-an inhibitor of deacetylase HDAC6 function. J. Neurochem. 2009, 109:1756-1766.
118. Petronis A. Epigenetics and twins: three variations on the theme. Trends Genet. 2006, 22:347-350.
119. Pfister J.A., Ma C., Morrison B.E., D'Mello S.R. Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS ONE 2008, 3:e4090.
120. Poulsen P., Esteller M., Vaag A., Fraga M.F. The epigenetic basis of twin discordance in age-related diseases. Pediatr. Res. 2007, 61:38R-42R.
121. Raiha I., Kaprio J., Koskenvuo M., Rajala T., Sourander L. Dementia in twins. Lancet 1996, 347:1706.
122. Rapp M.A., Schnaider-Beeri M., Grossman H.T., Sano M., Perl D.P., Purohit D.P., Gorman J.M., Haroutunian V. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. Arch. Gen. Psychiatry 2006, 63:161-167.
123. Rapp M.A., Schnaider-Beeri M., Purohit D.P., Perl D.P., Haroutunian V., Sano M. Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. Am. J. Geriatr. Psychiatry 2008, 16:168-174.
124. Reichenberg A., Mill J., MacCabe J.H. Epigenetics, genomic mutations and cognitive function. Cogn. Neuropsychiatry 2009, 14:377-390.
125. Richmond T.J., Davey C.A. The structure of DNA in the nucleosome core. Nature 2003, 423:145-150.
126. Ricobaraza A., Cuadrado-Tejedor M., Perez-Mediavilla A., Frechilla D., Del Rio J., Garcia-Osta A. Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model. Neuropsychopharmacology 2009, 34:1721-1732.
127. Rouaux C., Jokic N., Mbebi C., Boutillier S., Loeffler J.P., Boutillier A.L. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J. 2003, 22:6537-6549.
128. Rutten B.P., Mill J. Epigenetic mediation of environmental influences in major psychotic disorders. Schizophr. Bull. 2009, 35:1045-1056.
129. Ryu H., Barrup M., Kowall N.W., McKee A.C. P3-260: epigenetic modification in a monozygotic twin with Alzheimer's disease. Alzheimer's Demen. 2008, 4:T598-T1598.
130. Sasaki T., Maier B., Bartke A., Scrable H. Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell 2006, 5:413-422.
131. Scarmeas N., Luchsinger J.A., Schupf N., Brickman A.M., Cosentino S., Tang M.X., Stern Y. Physical activity, diet, and risk of Alzheimer disease. JAMA 2009, 302:627-637.
132. Scarpa S., Cavallaro R.A., D'Anselmi F., Fuso A. Gene silencing through methylation: an epigenetic intervention on Alzheimer disease. J. Alzheimers Dis. 2006, 9:407-414.
133. Scarpa S., Fuso A., D'Anselmi F., Cavallaro R.A. Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease?. FEBS Lett. 2003, 541:145-148.
134. Schumacher A., Petronis A. Epigenetics of complex diseases: from general theory to laboratory experiments. Curr. Top. Microbiol. Immunol. 2006, 310:81-115.
135. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
136. Selkoe D.J. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat. Cell Biol. 2004, 6:1054-1061.
137. Siegmund K.D., Connor C.M., Campan M., Long T.I., Weisenberger D.J., Biniszkiewicz D., Jaenisch R., Laird P.W., Akbarian S. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS One 2007, 2:e895.
138. Sierksma A.S., van den Hove D.L., Steinbusch H.W., Prickaerts J. Major depression, cognitive dysfunction and Alzheimer's disease: is there a link?. Eur. J. Pharmacol. 2010, 626:72-82.
139. Silva P.N., Gigek C.O., Leal M.F., Bertolucci P.H., de Labio R.W., Payao S.L., Smith Mde A. Promoter methylation analysis of SIRT3, SMARCA5, HTERT and CDH1 genes in aging and Alzheimer's disease. J. Alzheimers Dis. 2008, 13:173-176.
140. Silverman J.M., Ciresi G., Smith C.J., Marin D.B., Schnaider-Beeri M. Variability of familial risk of Alzheimer disease across the late life span. Arch. Gen. Psychiatry 2005, 62:565-573.
141. Small S.A., Duff K. Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 2008, 60:534-542.
142. Speranca M.A., Batista L.M., Lourenco Rda S., Tavares W.M., Bertolucci P.H., Rigolin Vde O., Payao S.L., Smith Mde A. Can the rDNA methylation pattern be used as a marker for Alzheimer's disease?. Alzheimer's Demen. 2008, 4:438-442.
143. Sugden C. One-carbon metabolism in psychiatric illness. Nutr. Res. Rev. 2006, 19:117-136.
144. Sweatt J.D. Behavioural neuroscience: down memory lane. Nature 2007, 447:151-152.
145. Szyf M., McGowan P., Meaney M.J. The social environment and the epigenome. Environ. Mol. Mutagen. 2008, 49:46-60.
146. Szyf M., Weaver I., Meaney M. Maternal care, the epigenome and phenotypic differences in behavior. Reprod. Toxicol. 2007, 24:9-19.
147. Tanzi R.E., Moir R.D., Wagner S.L. Clearance of Alzheimer's Abeta peptide: the many roads to perdition. Neuron 2004, 43:605-608.
148. Tohgi H., Utsugisawa K., Nagane Y., Yoshimura M., Genda Y., Ukitsu M. Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex. Brain Res. Mol. Brain Res. 1999, 70:288-292.
149. Tohgi H., Utsugisawa K., Nagane Y., Yoshimura M., Ukitsu M., Genda Y. The methylation status of cytosines in a tau gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex. Neurosci. Lett. 1999, 275:89-92.
150. Ulrey C.L., Liu L., Andrews L.G., Tollefsbol T.O. The impact of metabolism on DNA methylation. Hum. Mol. Genet. 2005, 14(Spec No. 1):R139-R147.
151. van Os J., Rutten B.P. Gene-environment-wide interaction studies in psychiatry. Am. J. Psychiatry 2009, 166:964-966.
152. van Os J., Rutten B.P., Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr. Bull. 2008, 34:1066-1082.
153. Wang S.C., Oelze B., Schumacher A. Age-specific epigenetic drift in late-onset Alzheimer's disease. PLoS ONE 2008, 3:e2698.
154. Weaver I.C. Epigenetic programming by maternal behavior and pharmacological intervention. Nature versus nurture: let's call the whole thing off. Epigenetics 2007, 2:22-28.
155. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., Dymov S., Szyf M., Meaney M.J. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7:847-854.
156. West R.L., Lee J.M., Maroun L.E. Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient. J. Mol. Neurosci. 1995, 6:141-146.
157. Wilson R.S., Arnold S.E., Schneider J.A., Kelly J.F., Tang Y., Bennett D.A. Chronic psychological distress and risk of Alzheimer's disease in old age. Neuroepidemiology 2006, 27:143-153.
158. Wilson V.L., Jones P.A. DNA methylation decreases in aging but not in immortal cells. Science 1983, 220:1055-1057.
159. Wilson V.L., Smith R.A., Ma S., Cutler R.G. Genomic 5-methyldeoxycytidine decreases with age. J. Biol. Chem. 1987, 262:9948-9951.
160. Wu J., Basha M.R., Brock B., Cox D.P., Cardozo-Pelaez F., McPherson C.A., Harry J., Rice D.C., Maloney B., Chen D., Lahiri D.K., Zawia N.H. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J. Neurosci. 2008, 28:3-9.
161. Yamamoto H., Schoonjans K., Auwerx J. Sirtuin functions in health and disease. Mol. Endocrinol. 2007, 21:1745-1755.
162. Yoshikai S., Sasaki H., Doh-ura K., Furuya H., Sakaki Y. Genomic organization of the human amyloid beta-protein precursor gene. Gene 1990, 87:257-263.
163. Zawia N.H., Lahiri D.K., Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radic. Biol. Med. 2009, 46:1241-1249.
164. Zhang Z.Y., Zhang Z., Fauser U., Schluesener H.J. Global hypomethylation defines a sub-population of reactive microglia/macrophages in experimental traumatic brain injury. Neurosci. Lett. 2007, 429:1-6.
165. Zukin S. Epigenetics. Alzheimer's Demen. 2009, 5:P146-P147.